Learn the benefits and features of the Oncomine Myeloid Assay GX.

1. Oncomine Myeloid Assay GX
One-day genomic profiling for myeloid samples
For Research Use Only. Not for use in diagnostic procedures. © 2020 Thermo Fisher Scientific Inc. All rights reserved.
All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. COL013171 0920
*
Specimen-to-report workflow will be available after the Ion Torrent™
Genexus™
Purification System and integrated reporting capabilities
are added in 2021.
Automated specimen-to-report workflow
Key features
✓ Whole blood
✓
Peripheral blood
leukocytes (PBLs)
✓ Bone marrow
Rapid
turnaround
Results in 1 day to
help provide critical
answers fast
Comprehensive
panel of biomarkers
DNA mutations and
RNA fusion transcripts
with one assay
Highly automated
10 minutes of hands-on
time, 2 user touchpoints
Ability to detect
challenging targets
Dedicated software and
excellent gene coverage
Integrated reporting
Fully annotated
variant report
Flexible batching
Sequence 1–8
samples at once
✓ Automated specimen-to-report
workflow, including library
preparation, sequencing,
variant calling, and reporting*
Ion Torrent™
Genexus™
System
Ion Torrent™
Oncomine™
Reporter
➡
➡ ✓ Annotated variant report
with biomarkers linked
to relevant evidence from
public data sources
Simultaneously interrogate DNA mutations and RNA
fusion transcripts covering all major myeloid disorders:
AML, MPN, MDS, CMML, and JMML
✓ 40 total genes
23 hotspot genes
17 full genes
✓ 29 RNA fusion drivers
600 fusion isotypes
✓ 5 gene expression genes
✓ 5 gene expression control genes
FLT3-ITD
PML-RARA
CEBPA
IDH1/2
MLLT3
SETBP1
SH2B3
SF3B1
ZRSR2
BCOR
TET2
CSF3R
CBL
NRAS MPL
NF1
NPM1
FTL3-TKD
PAX5-JAK2
CALR
STAG2
ASXL1
TP53
JAK2
WT1
BCR-ABL
RUNX1
NRAS
U2AF1
PTPN11
RUNX1-RUNX1T1
ETV6 KRAS
KIT
KMT2A
DNMT3A